Logo image
Back
Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024
Journal article   Open access   Peer reviewed

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

Kaitlin Benedict, Alexander Jordan, Jeremy A W Gold, Dallas J Smith, Tom Chiller, Ian Hennessee, Philip M Polgreen and Susan E Beekmann
Emerging infectious diseases, Vol.31(7), pp.1493-1495
07/01/2025
DOI: 10.3201/eid3107.250295
PMCID: PMC12205458
PMID: 40562736
url
https://doi.org/10.3201/eid3107.250295View
Open Access

Abstract

We polled infectious disease specialists about cryptococcal antigen screening for patients initiating HIV antiretroviral therapy. Of 215 respondents, 33% reported typically obtaining screening for patients with CD4 counts <200 cells/mm3 and 63% for counts <100 CD4 cells/mm3. Uncertainty about cryptococcal antigen screening benefits and recommendations suggests opportunities for education and increased screening.We polled infectious disease specialists about cryptococcal antigen screening for patients initiating HIV antiretroviral therapy. Of 215 respondents, 33% reported typically obtaining screening for patients with CD4 counts <200 cells/mm3 and 63% for counts <100 CD4 cells/mm3. Uncertainty about cryptococcal antigen screening benefits and recommendations suggests opportunities for education and increased screening.

Details

Metrics

1 Record Views
Logo image